Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: Implications for systemic therapy
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site identification is initially uncertain: A nationwide, multicenter, prospective study
JAAD Game Changers: Cutaneous adverse events of anti–programmed cell death-1 therapy in patients with metastatic melanoma: A single-institution cohort
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study
Equivalent disease-specific survival after Mohs micrographic surgery versus wide local excision for cutaneous leiomyosarcoma: A surveillance, epidemiology, and end results program-based analysis
The association between alcohol consumption and the severity of male androgenic alopecia in Chinese participants: A single-center cross-sectional study
Response to Hasan et al., “[Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: a retrospective cohort study]�
Response to Flynn et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study�
Response to Hasan et al., “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: A retrospective cohort study�
Response to “Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae�; Focus on griseofulvin
Response to Caplan et al, “Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae; Focus on Griseofulvin�
Response to Huang et al, “Risk of subsequent primary malignancies among survivors of adult-onset dermatofibrosarcoma protuberans: A population-based study�
Drivers of overall mortality in patients with pleomorphic dermal sarcoma: A population-based analysis of the Surveillance, Epidemiology, and End Results Program
Risk of mortality from visceral malignancies in patients with extramammary Paget's disease: A Surveillance, Epidemiology, and End Results (SEER) program-based analysis